1-(4-Bromo-2-methylphenyl)ethan-1-amine hydrochloride, 1g

N,N'-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydronaphthalene-1,7-diyl)diacetamide, 98%, 25mg

2,4-Dihydroxybenzaldehyd, min. 98 %, zur Synthese, 100 g, Glasverpackung

(R)-3-(piperidin-2-yl)pyridine, 97+%, 25mg

2-Oxo-2-(2-(trifluoromethyl)phenyl)acetic acid, 95%, 1g

TERT-BUTYL N-[2-(AZETIDIN-3-YL)PROPAN-2-YL]CARBAMATE HCL, 95.0%, 500mg

[(3-chloro-4-methoxyphenyl)methyl](methyl)amine, 97%, 250mg

3-(2-(METHOXYCARBONYL)PHENYL)PROPANOIC ACID, 95.0%, 1g

tert-Butyl 4-propionamidopiperidine-1-carboxylate, 95.0%, 1g

N-methyl-N-[(3R)-pyrrolidin-3-yl]acetamide hydrochloride, 95.0%, 1g

1-METHYL-1H-INDOLE-6-CARBOXYLIC ACID, 95.0%, 10g

2-Chloro-N-(2,3-dichloro-phenyl)-acetamide, 1g

4-Benzyloxy-5-bromo-2-(N,N-dimethylamino)pyrimidine, 96%, 1g